Related references
Note: Only part of the references are listed.Anti-HIV Drugs Cause Mitochondrial Dysfunction in Monocyte-Derived Macrophages
Jennillee Wallace et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)
The Impact of HIV- and ART-Induced Mitochondrial Dysfunction in Cellular Senescence and Aging
Madison Schank et al.
CELLS (2021)
Pharmacological advances in mitochondrial therapy
Aarti Singh et al.
EBIOMEDICINE (2021)
Role of Mitochondria in Viral Infections
Srikanth Elesela et al.
LIFE-BASEL (2021)
Effect of HIV infection and antiretroviral therapy on immune cellular functions
Marek Korencak et al.
JCI INSIGHT (2019)
HIV-Associated Cancers and Related Diseases
Robert Yarchoan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Mitofusin 2: from functions to disease
Riccardo Filadi et al.
CELL DEATH & DISEASE (2018)
Human immunodeficiency virus Tat impairs mitochondrial fission in neurons
Summer J. Rozzi et al.
CELL DEATH DISCOVERY (2018)
HIV-1 blocks the signaling adaptor MAVS to evade antiviral host defense after sensing of abortive HIV-1 RNA by the host helicase DDX3
Sonja I. Gringhuis et al.
NATURE IMMUNOLOGY (2017)
Pathophysiology of CD4+T-Cell Depletion in HIV-1 and HIV-2 infections
K. K. Vidya Vijayan et al.
FRONTIERS IN IMMUNOLOGY (2017)
Constitutively Active MAVS Inhibits HIV-1 Replication via Type I Interferon Secretion and Induction of HIV-1 Restriction Factors
Sachin Gupta et al.
PLOS ONE (2016)
Survival rate of AIDS disease and mortality in HIV-infected patients: a meta-analysis
J. Poorolajal et al.
PUBLIC HEALTH (2016)
In Vivo HIV-1 Cell-to-Cell Transmission Promotes Multicopy Micro-compartmentalized Infection
Kenneth M. Law et al.
CELL REPORTS (2016)
HIV protease inhibitors and onset of cardiovascular diseases: A central role for oxidative stress and dysregulation of the ubiquitin-proteasome system
Kathleen M. S. E. Reyskens et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Antiretroviral Therapy Current Drugs
Alice K. Pau et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2014)
Laboratory Diagnosis of HIV in Adults: A Review of Current Methods
Julia Kang Cornett et al.
CLINICAL INFECTIOUS DISEASES (2013)
Pathogenesis of HIV infection
Hassan M. Naif
INFECTIOUS DISEASE REPORTS (2013)
Mitophagy: mechanisms, pathophysiological roles, and analysis
Wen-Xing Ding et al.
BIOLOGICAL CHEMISTRY (2012)
HIV Pathogenesis: The Host
A. A. Lackner et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Oxidative Stress and Mitochondrial Impairment After Treatment with Anti-HIV Drugs: Clinical Implications
Ana Blas-Garcia et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
MEDICAL PROGRESS Acute HIV-1 Infection
Myron S. Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Enhanced oxidative stress and increased mitochondrial mass during Efavirenz-induced apoptosis in human hepatic cells
N. Apostolova et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Peroxisomes Are Signaling Platforms for Antiviral Innate Immunity
Evelyn Dixit et al.
CELL (2010)
Viral Defense: It Takes Two MAVs to Tango
Shruti Sharma et al.
CELL (2010)
Mitochondrial membrane potential and apoptosis of blood mononuclear cells in untreated HIV-1-infected patients
T. Sternfeld et al.
HIV MEDICINE (2009)
Innate immunity to virus infection
Osamu Takeuchi et al.
IMMUNOLOGICAL REVIEWS (2009)
Enhancing SIV-specific immunity in vivo by PD-1 blockade
Vijayakumar Velu et al.
NATURE (2009)
MAVS-Mediated Apoptosis and Its Inhibition by Viral Proteins
Yu Lei et al.
PLOS ONE (2009)
Inhibition of RIG-I and MDA5-dependent antiviral response by gC1qR at mitochondria
Lijuan Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Mitofusin 2 Inhibits Mitochondrial Antiviral Signaling
Kai Yasukawa et al.
SCIENCE SIGNALING (2009)
Immunopathogenesis of asymptomatic chronic HIV Infection: the calm before the storm
Emily S. Ford et al.
CURRENT OPINION IN HIV AND AIDS (2009)
Putting the kibosh on mitochondrial antiviral signaling
Robert P. Kruger
CELL (2008)
NLRX1 is a regulator of mitochondrial antiviral immunity
Chris B. Moore et al.
NATURE (2008)
Human immunodeficiency virus protease inhibitor ritonavir inhibits cholesterol efflux from human macrophage-derived foam cells
Xinwen Wang et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines
N. Duewelhenke et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Essential role of IPS-1 in innate immune responses against RNA viruses
Himanshu Kumar et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Anti-HIV drugs and the mitochondria
Marcello Pinti et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2006)
Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-κB and IRF3
RB Seth et al.
CELL (2005)
The CCR5 and CXCR4 coreceptors - Central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection
JP Moore et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2004)
Mitochondrial toxicity of NRTI antiviral drugs: An integrated cellular perspective
W Lewis et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Long-term metabolic consequences of switching from protease inhibitors to efavirenz in therapy for human immunodeficiency virus-infected patients with lipoatrophy
V Estrada et al.
CLINICAL INFECTIOUS DISEASES (2002)
The pathogenesis of HIV-1 infection
J Weber
BRITISH MEDICAL BULLETIN (2001)
Share Paper
